Albany Molecular Research ($AMRI) has announced plans to close a facility in Budapest, axing 100 jobs in the process. The contract research group and manufacturer says it plans to complete a restructuring in the second quarter. Story
| Thursday, September 24th | 1pm ET / 10am PT | Sponsored by: M-Files
This webinar will discus how the emergence of the ability to share documents and data across thousands of miles instantly has pulled biopharma companies in two opposing directions. Companies want, even need, the interconnectivity that is facilitated by the Internet, but feel equally strongly about controlling who can view and interact with their data. Register today!